GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » SPO Global Inc (OTCPK:SPOM) » Definitions » Construction In Progress

SPO Global (SPO Global) Construction In Progress : $0.00 Mil (As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is SPO Global Construction In Progress?


SPO Global Construction In Progress Historical Data

The historical data trend for SPO Global's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SPO Global Construction In Progress Chart

SPO Global Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

SPO Global Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep22 Sep23
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SPO Global Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


SPO Global (SPO Global) Business Description

Traded in Other Exchanges
N/A
Address
Jinan Pharma Valley, 27th Floor Block A J, Shandong, CHN, 33634
SPO Global Inc is a holding company whose strategic plan is to acquire interests in emerging young businesses and provide financing, advice and guidance to assist them in realizing their potential. The Company is implementing an acquisition roll-up model of acquiring sales, marketing, and manufacturing businesses. The business scope of the company includes bio-pharmaceutical Research and development, development and sales of medical informatization software, medical high-tech introduction, production and sales of medical quality supplies, dietary supplements, and medicine, as well as agents and sales of medical equipment supplies.
Executives
Jeffrey Louis Feuer officer: Chief Financial Officer 21860 BURBANK BLVD SUITE 380, WOODLAND HILLS CA 91367
Richard H Ryan officer: Chief Operating Officer 21860 BURBANK BLVD., NORTH BUILDING SUITE 380, WOODLAND HILLS CA 91367
Michael Braunold director, officer: Chief Executive Officer C/O AUBIENT CORP, 1033 BECON ST, BROOKLINE MA 02446
Sidney Braun director SUITE 404, 6711 MISSISSAUGA ROAD, MISSISSAUGA A6 L5N 2W3
Pauline Dorfman director 183 REINER ROAD, TORONTO A6 M3H 2L8
Israel Sarussi 10 percent owner, officer: Chief Technology Officer C/O SPO, SUITE 380, 21860 BURBANK BLVD., WOODLAND HILLS CA 91367